•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Tops Revenue Estimates
Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress
Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th
Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Envoy Medical Announces Reverse Stock Split
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
Envoy Medical (NASDAQ:COCH) vs. American Bio Medica (OTCMKTS:ABMC) Critical Review
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
Envoy Medical Terminates At-the-Market (ATM) Equity Facility
Envoy Medical to Present at Investor Conferences on June 25th
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th